Latest Clinical & Research News
Specialty: OB/GYN
Brigham and Women’s Hospital is ranked #1 in the nation for obstetrics and gynecology by U.S. News & World Report 2022-23. Nawal Nour, MD, MPH, chair of the Department of Obstetrics and Gynecology, discusses how the team’s dedication and perseverance has contributed to this major accomplishment.
Read More...
David J. Cote, MD, PhD, and Meir J. Stampfer, MD, DrPH, of the Channing Division of Network Medicine at Brigham and Women’s Hospital, and colleagues have conducted the first prospective study of associations between pituitary adenoma and the use of oral contraceptives or menopausal hormone therapy.
Read More...
Leaders from the Brigham’s Department of Pediatric Newborn Medicine presented their latest research to thousands of attendees at the 2022 Pediatric Academic Societies’ meeting. The department had a strong presence at this event, which took place April 21 – 25, 2022, in Denver, CO.
Read More...
Researchers have shown that a novel molecular signature from a single blood sample can identify women at risk of preeclampsia months before presentation. They also report that molecular signatures accurately track gestational age, independently of clinical factors, and could advance the study of other complications.
Read More...
In the first study of its kind, Iwona Gabriel, MD, PhD, and Vatche A. Minassian, MD, MPH, of the Urogynecology Group, and colleagues found women and adolescents with surgically confirmed endometriosis are at substantially greater risk than others of having multiple lower urinary tract symptoms.
Read More...
Brigham researchers recently confirmed that administration of acidified human milk fortifier is associated with higher incidence of metabolic acidosis in the first weeks of life for very-low-birthweight infants, but the type of fortifier was not an important determinant of growth during the NICU stay.
Read More...
Raina Fichorova, MD, PhD, director of the Laboratory of Genital Tract Biology, is a leader in studying host-microbe interactions in the female reproductive tract. Her efforts have included developing a novel “live” biotherapeutic treatment, which she has patented and is now working to bring into clinical trials.
Read More...
Raina N. Fichorova, MD, PhD, and Hidemi S. Yamamoto, BA, of the Laboratory of Genital Tract Biology in the Department of Obstetrics and Gynecology at the Brigham, and colleagues have discovered concurrent exposure to Trichomonas vaginalis and bacterial vaginosis dysregulates the expression of galectins.
Read More...
In a nationwide online survey of pregnant and postpartum women, Cindy H. Liu, PhD, and Carmina Erdei, MD, of Brigham and Women’s Hospital, and colleagues determined that psychological factors related to COVID-19, particularly grief, pose unique hazards to mother–infant bonding.
Read More...
David E. Cantonwine, PhD, of the Division of Maternal–Fetal Medicine at Brigham and Women’s Hospital, and colleagues recently conducted the first study of PFAS and preeclampsia that distinguished between early- and late-onset preeclampsia, which have different risk factors, severities and pathophysiologies.
Read More...